EAVE II logo

Pre-print: Impact of antiviral and monoclonal antibody treatments on serious COVID-19 outcomes

March 2023: Scottish study looks at the risk of people experiencing serious COVID-19 illness after being treated with antivirals and/or neutralising monoclonal antibodies, and estimates how effective these treatments are compared to one another

Real-World Severe COVID-19 Outcomes Associated with Use of Antivirals and Neutralising Monoclonal Antibodies: A Population-Based Retrospective Cohort Study in Scotland

Tibble, H; Mueller, T; Proud, E; Hall, E; et. al.

preprints with The Lancet

Published online on: 2 March 2023

Available online at: https://papers.ssrn.com/sol3/papers.cfm?abstract_id=4356763